SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-18-001224
Filing Date
2018-01-03
Accepted
2018-01-03 18:01:48
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4404
  Complete submission text file 0001209191-18-001224.txt   5873
Mailing Address THE SCRIPPS RESEARCH INSTITUTE 10550 N. TORREY PINES ROAD LA JOLLA CA 92037
Business Address
LERNER RICHARD A (Reporting) CIK: 0001316274 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36274 | Film No.: 18507206

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations